Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance
S Beena
Authors registered in the RePEc Author Service: Beena Saraswathy
MPRA Paper from University Library of Munich, Germany
Abstract:
This paper tries to address the extent, nature and impact of the recent surge in consolidation strategies especially in the form of mergers and acquisitions followed by the firms in the Indian pharmaceutical industry. The study found that many of the firms are implementing these strategies in the new context of globalisation mainly to overcome the acute competition arising out of the pro-market reforms and to strengthen their market portfolio. The study reaches the conclusion that the consolidation strategies followed by the firms enabled them to cut down the wasteful expenses to a greater extent and which resulted in better performance of the merging firms compared to the non-merging firms in this industry.
Keywords: mergers; acquisitions; consolidation; pharmaceutical industry; performance (search for similar items in EconPapers)
JEL-codes: G34 L6 L80 (search for similar items in EconPapers)
Date: 2006-06-28, Revised 2007-06-28
New Economics Papers: this item is included in nep-cfn, nep-com, nep-cse, nep-cwa and nep-ind
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (8) Track citations by RSS feed
Downloads: (external link)
https://mpra.ub.uni-muenchen.de/8144/1/MPRA_paper_8144.pdf original version (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:8144
Access Statistics for this paper
More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().